2019
DOI: 10.1097/pas.0000000000001217
|View full text |Cite
|
Sign up to set email alerts
|

CRTC1-TRIM11 Fusion in a Case of Metastatic Clear Cell Sarcoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 5 publications
1
17
0
Order By: Relevance
“…Except for one case with metastasis 13 years after diagnosis, none have recurred following excision after a median follow-up of 12 months (range 1 month to 13 years). 1,2,5,6,23 Histopathologically, CMCT is typically a well-circumscribed, unencapsulated dermal tumor with nodular to multinodular borders. 7 Our case is the first example of a compound CMCT showing considerable epidermal involvement.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Except for one case with metastasis 13 years after diagnosis, none have recurred following excision after a median follow-up of 12 months (range 1 month to 13 years). 1,2,5,6,23 Histopathologically, CMCT is typically a well-circumscribed, unencapsulated dermal tumor with nodular to multinodular borders. 7 Our case is the first example of a compound CMCT showing considerable epidermal involvement.…”
Section: Discussionmentioning
confidence: 99%
“…Suggested clinical diagnoses have included dermatofibroma, epidermal cyst, Spitz nevus, melanoma, and pyogenic granuloma. Except for one case with metastasis 13 years after diagnosis, none have recurred following excision after a median follow‐up of 12 months (range 1 month to 13 years) 1,2,5,6,23 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Twelve out of the thirteen cases showed no recurrence of disease after a median follow‐up of 12 months. One case revealed a metastasis 13 years after the initial diagnosis 111 . Based on this finding, Bontoux et al 111 suggested that this tumor should be reclassified as a CCS with a novel CRTC1::TRIM11 fusion.…”
Section: Clear Cell Sarcomamentioning
confidence: 99%
“…One case revealed a metastasis 13 years after the initial diagnosis 111 . Based on this finding, Bontoux et al 111 suggested that this tumor should be reclassified as a CCS with a novel CRTC1::TRIM11 fusion. However, while the cutaneous melanocytic tumor with CRTC1::TRIM11 fusion has a morphological and immunohistochemical resemblance to CCS, it is composed of larger cells, with moderate to severe cytologic atypia, brisk mitotic activity, and well‐defined borders compared to CCS.…”
Section: Clear Cell Sarcomamentioning
confidence: 99%